Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.13

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.13). Revenue for the quarter came in at $9.1 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Chagee Holdings (CHA) Tops Q2 EPS by 3c
• BiomX announces 1-for-10 reverse stock split effective Sept. 9